GlassScriptPhysician profile
John Alexander Watson
NPI 1619321205
$14,733.56
in general payments reported to CMS, 2019-2025
25 companies · $2,427 in 2025
The $2,427 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $2,749 · 2021: $5,245 · 2022: $1,972 · 2023: $643 · 2024: $1,065 · 2025: $2,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,635 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,634.97 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $6,793.83 | 2020-2021 | |
| Bone Support INC. | $1,598.16 | 2025 | Ceramentbone Void Filler, Cerament G |
| Zimmer Biomet Holdings, INC. | $1,503.94 | 2022-2023 | Stratum Foot Plating System |
| Smith+Nephew, INC. | $1,257.83 | 2019-2025 | Stravix Mesh, Grafix Pl, Stravix Pl |
| Stryker Corporation | $1,041.94 | 2019-2025 | Augment Injectable, Prophecy, Citrefix |
| Arthrex, INC. | $411.01 | 2021-2024 | Arthrex |
| Eclipse Technology Solutions INC. | $311.95 | 2023-2025 | |
| Zyla Life Sciences, INC. | $266.31 | 2019 | |
| Misonix INC | $252.54 | 2020-2021 | |
| Abbvie INC. | $183.90 | 2023-2025 | Dalvance |
| Organogenesis INC. | $172.29 | 2019-2022 | |
| Treace Medical Concepts, INC. | $164.09 | 2022-2025 | |
| Grt US Holding, INC. | $120.29 | 2022 | |
| Depuy Synthes Sales INC. | $117.05 | 2019 | |
| Paratek Pharmaceuticals, INC. | $92.45 | 2020-2024 | Nuzyra |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $90.25 | 2019-2023 | Activ.A.C. |
| Sanara Medtech INC. | $79.41 | 2025 | Celleraterx |
| Lifenet Health | $74.23 | 2025 | Theragenesis Wound Matrix |
| Medshape, INC. | $63.28 | 2024 | Dynanail |
| Kerecis Limited | $56.09 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Acera Surgical, INC. | $24.81 | 2022 | |
| Integra Lifesciences Corporation | $19.97 | 2021 | |
| Biotissue Holdings INC. | $17.50 | 2022 | |
| Orthofix Medical, INC. | $11.96 | 2025 | Physio-Stim |
| Cashflow Solutions, LLC | $8.48 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.